Each year, MNGI Digestive Health (MNGI) tracks and reports on key Colonoscopy Quality Measures for their gastroenterologists. MNGI’s 2023 Adenoma Detection Rate (ADR) data has just been released showing their physicians’ ability to locate and remove precancerous polyps during screening colonoscopies.
The statistics are impressive. When compared to performance targets set by the American Society for Gastrointestinal Endoscopy (ASGE), MNGI gastroenterologists ADR performance is more than two times the national benchmark for male patients and nearly three times the national benchmark for female patients.
This means when a colonoscopy is performed by a MNGI provider, the risk of developing colorectal cancer in the next 5-10 years drops considerably as compared to results from other providers.
When considering where to have your next screening colonoscopy performed, trust the experts at MNGI and make the smartest choice when it comes to preventing your own cancer. Learn more about ADR and other quality measures that MNGI monitors on the Quality & Outcomes section of our About Us page.
